News | April 27, 2010

Study Shows Link Between Atrial Fibrillation, Dementia

April 27, 2010 – New findings confirm atrial fibrillation (AF) is independently associated with the risk of all forms of dementia, including Alzheimer’s and other senile and vascular dementia types. According to a study published in the April edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, the presence of AF indicated higher mortality rates in all dementia subtypes. However, mortality risk was most prominent in the youngest population studied.

The study evaluated 37,025 patients from the Intermountain Heart Collaborative Study database between the ages of 60 and 90 years over a five-year period. The study population included all patients who were seen by cardiologists for the development of atrial fibrillation and different types of dementia including vascular, senile, Alzheimer’s and other nonspecified types. During the study, a total of 10,161 patients (27 percent) developed AF and 1,535 (4.1 percent) developed dementia. Researchers also assessed the impact of AF on mortality risk in those patients diagnosed with dementia.

Study findings revealed AF is independently associated with all dementia types and, across all dementia states, cognitive decline occurred earlier in patients with AF versus no AF. Among the 764 patients who developed both AF and dementia, AF developed first, or in some cases simultaneously with dementia diagnosis. Most notably, the greatest risk of dementia was seen in the youngest AF patient group (less than 70 years old). Furthermore, the greatest increased risk of mortality was also observed in the youngest patient group.

“While age remains the strongest risk factor for dementia, our study shows the highest risk of Alzheimer’s and other dementia types was most prominent in the youngest AF patient group,” said lead author T. Jared Bunch, M.D., heart rhythm specialist, Intermountain Medical Center, Murray, Utah. “This finding is significant in establishing the association between dementia and AF and could potentially help clinicians monitor patients more closely for signs of dementia and mortality risks.”

With more than 2 million people in the United States diagnosed with atrial fibrillation, this study is an important step toward improving prevention and overall patient care. Further research may establish treatment methods for AF patients living with dementia and help reduce the mortality risk.

For more information: www.heartrhythmjournal.com

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init